Search Results 1881-1890 of 16105 for Epilepsy (Partial Onset)
... EPILEPSY WITH NEUROSTIMULATOR,148601.65 MS024,CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITHOUT MCC,111024.12 MS025 ...
The group's results showed that rituximab is not inferior to cyclosporine in inducing complete or partial remission of proteinuria for 12 months and is ...
The purpose of this study is to investigate the onset and maintenance of effect of benralizumab on lung function, blood eosinophils, asthma control metrics and ...
These headaches can happen after a spinal tap procedure or spinal anesthesia, and usually don't require treatment.
Subjects will be allowed to take their chronic medications unless excluded by the protocol including remaining constant throughout the duration of the study.
... . Ability to comply with outpatient treatment, laboratory monitoring, and required clinic visits for the duration of study participation. For ...
Previous treatment with 1 or more JAK inhibitors (licensed or experimental) for a minimum duration of at least 4 weeks and failure to achieve or sustain ...
... epilepsy. E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS). Rochester, Minn., Jacksonville, Fla ...
Steve Day participated in a research study at Mayo Clinic to try to slow the progression of multiple system atrophy.
... duration of the study. This includes significant active and poorly controlled (unstable) cardiovascular disorders and untreated hypo- or hyperthyroidism ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.